ENVB EnvericBio +3% Holds Yesterdays Pullback on Analyst Price Target Now at $6.00 – June 30, 2021
Company Profile Enveric Biosciences (NASDAQ: ENVB) is a patient-centric biotechnology company endeavoring to enhance the lives of those who are …
source